During the past decade, Miedzyleski Szpital Specjalistyczny w Warszawie conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 10 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 7 clinical trials were completed. i.e. 175% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Miedzyleski Szpital Specjalistyczny w Warszawie" #1 sponsor was "Shire" with 5 trials, followed by "Hoffmann-La Roche" with 3 trials sponsored, "Pfizer" with 2 trials sponsored, "Bavarian Nordic" with 1 trials sponsored and "Biogen" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Miedzyleski Szpital Specjalistyczny w Warszawie" #1 collaborator was "Chugai Pharmaceutical" with 1 trials as a collaborator and "Otsuka Pharmaceutical Co., Ltd." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Miedzyleski Szpital Specjalistyczny w Warszawie" are "Crohn's Disease" (3 trials), "Ulcerative Colitis" (3 trials), "Acute Coronary Syndrome" (1 trials), "Chronic Obstructive Pulmonary Disease" (1 trials) and "Coronary Artery Disease" (1 trials). Many other conditions were trialed in "Miedzyleski Szpital Specjalistyczny w Warszawie" in a lesser frequency.

Most popular intervention types in "Miedzyleski Szpital Specjalistyczny w Warszawie" are "Drug" (16 trials), "Other" (5 trials), "Biological" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Ontamalimab" (4 trials), "25 mg Ontamalimab" (1 trials), "75 mg Ontamalimab" (1 trials) and "Atrasentan" (1 trials). Other intervention names were less common.

The vast majority of trials in "Miedzyleski Szpital Specjalistyczny w Warszawie" are 16 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Miedzyleski Szpital Specjalistyczny w Warszawie". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Miedzyleski Szpital Specjalistyczny w Warszawie, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Miedzyleski Szpital Specjalistyczny w Warszawie, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".